| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 3.67e-10 | 5 | 60 | 4 | GO:0005471 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A2 SLC7A8 GPM6A SLC6A9 ABCG1 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 KCNJ3 SLC35B3 SLC25A38 GJC1 PKD2L1 ANO5 PKD1L3 SLC35B1 | 5.86e-09 | 1180 | 60 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 6.67e-09 | 23 | 60 | 5 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.29e-08 | 26 | 60 | 5 | GO:0000295 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A2 SLC7A8 SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 SLC35B1 | 1.73e-08 | 296 | 60 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.27e-08 | 59 | 60 | 6 | GO:1901505 | |
| GeneOntologyMolecularFunction | transporter activity | SLC6A2 SLC7A8 GPM6A SLC6A9 ABCG1 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 KCNJ3 SLC35B3 SLC25A38 GJC1 PKD2L1 ANO5 PKD1L3 SLC35B1 | 2.31e-08 | 1289 | 60 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 2.32e-08 | 29 | 60 | 5 | GO:0015216 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 2.39e-08 | 11 | 60 | 4 | GO:0015217 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 4.60e-08 | 33 | 60 | 5 | GO:0015215 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 7.21e-08 | 14 | 60 | 4 | GO:0005347 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.10e-07 | 39 | 60 | 5 | GO:0015605 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A2 SLC7A8 SLC6A9 ABCG1 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 SLC35B1 | 1.54e-07 | 477 | 60 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | antiporter activity | 1.84e-07 | 138 | 60 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC7A8 SLC6A9 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 SLC25A38 SLC35B1 | 2.14e-07 | 293 | 60 | 9 | GO:0008514 |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 9.13e-07 | 59 | 60 | 5 | GO:0015932 | |
| GeneOntologyMolecularFunction | glycine transmembrane transporter activity | 3.05e-06 | 10 | 60 | 3 | GO:0015187 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A2 GPM6A SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC15A4 KCNJ3 GJC1 PKD2L1 ANO5 PKD1L3 | 3.43e-06 | 793 | 60 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 5.01e-06 | 83 | 60 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | sour taste receptor activity | 8.88e-06 | 2 | 60 | 2 | GO:0033040 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A2 GPM6A SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 ANO5 PKD1L3 | 1.37e-05 | 758 | 60 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A2 GPM6A SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 PKD1L3 | 1.59e-05 | 627 | 60 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A2 GPM6A SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 PKD1L3 | 2.59e-05 | 664 | 60 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | 6-phosphofructokinase activity | 2.66e-05 | 3 | 60 | 2 | GO:0003872 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 6.16e-05 | 71 | 60 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 8.83e-05 | 5 | 60 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 8.83e-05 | 5 | 60 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 8.83e-05 | 5 | 60 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.85e-04 | 7 | 60 | 2 | GO:0008443 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.53e-04 | 41 | 60 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.81e-04 | 105 | 60 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 3.93e-04 | 10 | 60 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.72e-04 | 465 | 60 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 4.80e-04 | 11 | 60 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 5.75e-04 | 12 | 60 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.10e-03 | 151 | 60 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.74e-03 | 171 | 60 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | AMP binding | 1.80e-03 | 21 | 60 | 2 | GO:0016208 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 1.80e-03 | 21 | 60 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.50e-03 | 459 | 60 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 2.75e-03 | 26 | 60 | 2 | GO:0004435 | |
| GeneOntologyMolecularFunction | monosaccharide binding | 2.93e-03 | 95 | 60 | 3 | GO:0048029 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 3.11e-03 | 97 | 60 | 3 | GO:0008081 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.19e-03 | 28 | 60 | 2 | GO:0000030 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 3.42e-03 | 29 | 60 | 2 | GO:0004629 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.48e-03 | 207 | 60 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.54e-03 | 208 | 60 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | taste receptor activity | 4.42e-03 | 33 | 60 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | channel activity | 4.84e-03 | 525 | 60 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.88e-03 | 526 | 60 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | phospholipase activity | 4.90e-03 | 114 | 60 | 3 | GO:0004620 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.52e-03 | 119 | 60 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 6.01e-03 | 386 | 60 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.89e-03 | 129 | 60 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | lipase activity | 8.29e-03 | 138 | 60 | 3 | GO:0016298 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 1.03e-02 | 51 | 60 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | symporter activity | 1.04e-02 | 150 | 60 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.27e-02 | 301 | 60 | 4 | GO:0022853 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 1.20e-08 | 96 | 60 | 7 | GO:1901264 | |
| GeneOntologyBiologicalProcess | ADP transport | 3.15e-08 | 12 | 60 | 4 | GO:0015866 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 1.07e-07 | 40 | 60 | 5 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 1.38e-07 | 42 | 60 | 5 | GO:0051503 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.75e-07 | 44 | 60 | 5 | GO:0015865 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 2.33e-07 | 5 | 60 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 3.37e-07 | 50 | 60 | 5 | GO:0006862 | |
| GeneOntologyBiologicalProcess | ATP transport | 5.50e-07 | 23 | 60 | 4 | GO:0015867 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A2 GPM6A SLC6A9 SLC8B1 ZMPSTE24 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 GJC1 PKD2L1 CCR1 CASR ANO5 PKD1L3 | 1.26e-06 | 1374 | 60 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 1.30e-06 | 8 | 60 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 1.92e-06 | 31 | 60 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC7A8 SLC6A9 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 SLC25A38 CASR SLC35B1 | 2.12e-06 | 515 | 60 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A2 GPM6A SLC6A9 SLC8B1 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 GJC1 PKD2L1 CASR ANO5 PKD1L3 | 2.81e-06 | 1115 | 60 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A2 GPM6A SLC6A9 SLC8B1 ZMPSTE24 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 CCR1 CASR PKD1L3 | 4.32e-06 | 1157 | 60 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 5.47e-06 | 40 | 60 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A2 GPM6A SLC6A9 SLC8B1 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 CASR ANO5 PKD1L3 | 5.62e-06 | 1017 | 60 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 7.54e-06 | 162 | 60 | 6 | GO:0015748 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of sour taste | 8.32e-06 | 2 | 60 | 2 | GO:0001581 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.04e-05 | 15 | 60 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | glycine transport | 1.04e-05 | 15 | 60 | 3 | GO:0015816 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 1.42e-05 | 106 | 60 | 5 | GO:1990542 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 3.98e-05 | 23 | 60 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 4.53e-05 | 24 | 60 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 5.80e-05 | 26 | 60 | 3 | GO:1905709 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A2 GPM6A SLC6A9 SLC8B1 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 PKD1L3 | 6.16e-05 | 922 | 60 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | organic cation transport | 6.41e-05 | 145 | 60 | 5 | GO:0015695 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A2 GPM6A SLC6A9 SLC8B1 TMEM168 SLC25A4 SLC25A5 SLC15A4 KCNJ3 PKD2L1 PKD1L3 | 7.47e-05 | 942 | 60 | 11 | GO:0098655 |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 1.20e-04 | 33 | 60 | 3 | GO:0097345 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.20e-04 | 87 | 60 | 4 | GO:1902475 | |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 1.24e-04 | 6 | 60 | 2 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 1.24e-04 | 6 | 60 | 2 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 1.24e-04 | 6 | 60 | 2 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 1.24e-04 | 6 | 60 | 2 | GO:0018103 | |
| GeneOntologyBiologicalProcess | adenine transport | 1.24e-04 | 6 | 60 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A2 GPM6A SLC6A9 SLC8B1 ZMPSTE24 TMEM168 KCNJ3 PKD2L1 CCR1 CASR PKD1L3 | 1.27e-04 | 1000 | 60 | 11 | GO:0030001 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.50e-04 | 684 | 60 | 9 | GO:0010817 | |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 1.69e-04 | 37 | 60 | 3 | GO:0034250 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 2.14e-04 | 40 | 60 | 3 | GO:1902110 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 2.48e-04 | 42 | 60 | 3 | GO:1902686 | |
| GeneOntologyBiologicalProcess | amino acid transport | 2.57e-04 | 195 | 60 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | cellular response to lipoprotein particle stimulus | 2.66e-04 | 43 | 60 | 3 | GO:0071402 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.77e-04 | 108 | 60 | 4 | GO:0015807 | |
| GeneOntologyBiologicalProcess | fructose 1,6-bisphosphate metabolic process | 2.96e-04 | 9 | 60 | 2 | GO:0030388 | |
| GeneOntologyBiologicalProcess | sensory perception of sour taste | 2.96e-04 | 9 | 60 | 2 | GO:0050915 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 3.04e-04 | 45 | 60 | 3 | GO:0035794 | |
| GeneOntologyBiologicalProcess | mitochondrial transport | 3.24e-04 | 205 | 60 | 5 | GO:0006839 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 3.46e-04 | 208 | 60 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 3.92e-04 | 49 | 60 | 3 | GO:1902108 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 4.13e-04 | 120 | 60 | 4 | GO:0003333 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 4.16e-04 | 50 | 60 | 3 | GO:1905710 | |
| GeneOntologyBiologicalProcess | purine nucleobase transport | 5.39e-04 | 12 | 60 | 2 | GO:0006863 | |
| GeneOntologyBiologicalProcess | peptide transport | 5.70e-04 | 355 | 60 | 6 | GO:0015833 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 5.87e-04 | 357 | 60 | 6 | GO:0009101 | |
| GeneOntologyBiologicalProcess | aromatic amino acid transport | 6.36e-04 | 13 | 60 | 2 | GO:0015801 | |
| GeneOntologyBiologicalProcess | nucleobase transport | 6.36e-04 | 13 | 60 | 2 | GO:0015851 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 6.67e-04 | 509 | 60 | 7 | GO:0006816 | |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 7.12e-04 | 60 | 60 | 3 | GO:0015804 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 7.83e-04 | 249 | 60 | 5 | GO:0015931 | |
| GeneOntologyBiologicalProcess | cellular response to peptide | 8.53e-04 | 15 | 60 | 2 | GO:1901653 | |
| GeneOntologyBiologicalProcess | cellular response to acidic pH | 8.53e-04 | 15 | 60 | 2 | GO:0071468 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability | 9.40e-04 | 66 | 60 | 3 | GO:0046902 | |
| GeneOntologyBiologicalProcess | positive regulation of mitophagy | 9.73e-04 | 16 | 60 | 2 | GO:1901526 | |
| GeneOntologyBiologicalProcess | fructose 6-phosphate metabolic process | 9.73e-04 | 16 | 60 | 2 | GO:0006002 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.22e-03 | 275 | 60 | 5 | GO:0006814 | |
| GeneOntologyBiologicalProcess | circulatory system process | 1.22e-03 | 733 | 60 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.30e-03 | 163 | 60 | 4 | GO:1905039 | |
| GeneOntologyBiologicalProcess | amide transport | 1.36e-03 | 420 | 60 | 6 | GO:0042886 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 1.38e-03 | 19 | 60 | 2 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 1.38e-03 | 19 | 60 | 2 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 1.38e-03 | 19 | 60 | 2 | GO:0086014 | |
| GeneOntologyBiologicalProcess | positive regulation of autophagy of mitochondrion | 1.38e-03 | 19 | 60 | 2 | GO:1903599 | |
| GeneOntologyBiologicalProcess | glycosaminoglycan biosynthetic process | 1.41e-03 | 76 | 60 | 3 | GO:0006024 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.42e-03 | 167 | 60 | 4 | GO:1903825 | |
| GeneOntologyBiologicalProcess | dopamine uptake | 1.53e-03 | 20 | 60 | 2 | GO:0090494 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate biosynthetic process | 1.53e-03 | 20 | 60 | 2 | GO:0030206 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 1.53e-03 | 430 | 60 | 6 | GO:0009100 | |
| GeneOntologyBiologicalProcess | hormone transport | 1.57e-03 | 432 | 60 | 6 | GO:0009914 | |
| GeneOntologyBiologicalProcess | aminoglycan biosynthetic process | 1.64e-03 | 80 | 60 | 3 | GO:0006023 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.69e-03 | 21 | 60 | 2 | GO:0006735 | |
| GeneOntologyBiologicalProcess | catecholamine uptake | 1.69e-03 | 21 | 60 | 2 | GO:0090493 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.69e-03 | 21 | 60 | 2 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.69e-03 | 21 | 60 | 2 | GO:0061718 | |
| GeneOntologyBiologicalProcess | regulation of membrane permeability | 1.82e-03 | 83 | 60 | 3 | GO:0090559 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta formation | 2.02e-03 | 23 | 60 | 2 | GO:1902004 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin D | 2.02e-03 | 23 | 60 | 2 | GO:0071305 | |
| GeneOntologyBiologicalProcess | regulation of amide metabolic process | 2.15e-03 | 88 | 60 | 3 | GO:0034248 | |
| GeneOntologyBiologicalProcess | protein mannosylation | 2.39e-03 | 25 | 60 | 2 | GO:0035268 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 2.39e-03 | 25 | 60 | 2 | GO:0019677 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 2.39e-03 | 25 | 60 | 2 | GO:0061620 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 2.57e-03 | 326 | 60 | 5 | GO:1903522 | |
| GeneOntologyBiologicalProcess | mannosylation | 2.59e-03 | 26 | 60 | 2 | GO:0097502 | |
| GeneOntologyBiologicalProcess | cellular response to pH | 2.59e-03 | 26 | 60 | 2 | GO:0071467 | |
| GeneOntologyBiologicalProcess | chondroitin sulfate proteoglycan biosynthetic process | 2.59e-03 | 26 | 60 | 2 | GO:0050650 | |
| GeneOntologyBiologicalProcess | response to acidic pH | 2.79e-03 | 27 | 60 | 2 | GO:0010447 | |
| GeneOntologyBiologicalProcess | peptide hormone secretion | 2.85e-03 | 334 | 60 | 5 | GO:0030072 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | OR2C1 LMAN1L CDS1 ABCG1 DPY19L3 SRD5A3 ZMPSTE24 SLC35B3 GJC1 ANO5 RNF175 SPPL2B FADS2B SLC35B1 | 1.62e-05 | 1293 | 61 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | OR2C1 LMAN1L CDS1 ABCG1 DPY19L3 SRD5A3 ZMPSTE24 SLC35B3 GJC1 ANO5 RNF175 SPPL2B FADS2B SLC35B1 | 1.70e-05 | 1299 | 61 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | OR2C1 LMAN1L CDS1 ABCG1 DPY19L3 SRD5A3 ZMPSTE24 SLC35B3 GJC1 ANO5 RNF175 SPPL2B FADS2B SLC35B1 | 2.16e-05 | 1327 | 61 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | 6-phosphofructokinase complex | 2.51e-05 | 3 | 61 | 2 | GO:0005945 | |
| GeneOntologyCellularComponent | organelle inner membrane | DPY19L3 SLC8B1 ZMPSTE24 SLC25A4 SLC25A5 SLC25A6 DPY19L4 COA1 SLC25A38 | 1.08e-04 | 652 | 61 | 9 | GO:0019866 |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 1.74e-04 | 7 | 61 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | Golgi membrane | XYLT1 LMAN1L ABCG1 SLC35B3 CHST12 SMPD3 RNF175 SPPL2B SLC35B1 | 2.29e-04 | 721 | 61 | 9 | GO:0000139 |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 2.68e-04 | 43 | 61 | 3 | GO:0098688 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 6.84e-04 | 59 | 61 | 3 | GO:0005637 | |
| GeneOntologyCellularComponent | pore complex | 2.60e-03 | 26 | 61 | 2 | GO:0046930 | |
| MousePheno | abnormal tibia morphology | 6.02e-06 | 375 | 38 | 8 | MP:0000558 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 6.76e-06 | 381 | 38 | 8 | MP:0003857 | |
| MousePheno | abnormal periosteum morphology | 2.15e-05 | 3 | 38 | 2 | MP:0010971 | |
| MousePheno | abnormal bone trabecula morphology | 2.92e-05 | 134 | 38 | 5 | MP:0010867 | |
| MousePheno | decreased bone trabecula number | 3.74e-05 | 70 | 38 | 4 | MP:0010869 | |
| MousePheno | rib fractures | 4.30e-05 | 4 | 38 | 2 | MP:0004675 | |
| MousePheno | abnormal long bone morphology | 6.32e-05 | 676 | 38 | 9 | MP:0003723 | |
| MousePheno | abnormal trabecular bone morphology | 1.17e-04 | 289 | 38 | 6 | MP:0000130 | |
| MousePheno | abnormal limb long bone morphology | 1.17e-04 | 568 | 38 | 8 | MP:0011504 | |
| MousePheno | abnormal hindlimb morphology | 1.29e-04 | 576 | 38 | 8 | MP:0000556 | |
| MousePheno | abnormal limb bone morphology | 1.48e-04 | 587 | 38 | 8 | MP:0002115 | |
| MousePheno | increased trabecular bone connectivity density | 3.90e-04 | 11 | 38 | 2 | MP:0010932 | |
| MousePheno | abnormal appendicular skeleton morphology | 5.28e-04 | 896 | 38 | 9 | MP:0009250 | |
| Domain | Mit_uncoupling | 6.46e-06 | 12 | 59 | 3 | IPR002030 | |
| Domain | SOLCAR | 2.34e-05 | 53 | 59 | 4 | PS50920 | |
| Domain | Mito_carr | 2.34e-05 | 53 | 59 | 4 | PF00153 | |
| Domain | - | 2.34e-05 | 53 | 59 | 4 | 1.50.40.10 | |
| Domain | Mt_carrier_dom | 2.34e-05 | 53 | 59 | 4 | IPR023395 | |
| Domain | Mitochondrial_sb/sol_carrier | 2.34e-05 | 53 | 59 | 4 | IPR018108 | |
| Domain | ATP_PFK | 2.94e-05 | 3 | 59 | 2 | IPR022953 | |
| Domain | PHOSPHOFRUCTOKINASE | 2.94e-05 | 3 | 59 | 2 | PS00433 | |
| Domain | 6-Pfructokinase_euk | 2.94e-05 | 3 | 59 | 2 | IPR009161 | |
| Domain | Phosphofructokinase_CS | 2.94e-05 | 3 | 59 | 2 | IPR015912 | |
| Domain | PFK | 2.94e-05 | 3 | 59 | 2 | PF00365 | |
| Domain | Phosphofructokinase_dom | 2.94e-05 | 3 | 59 | 2 | IPR000023 | |
| Domain | UAA | 5.86e-05 | 4 | 59 | 2 | IPR013657 | |
| Domain | EMP70 | 5.86e-05 | 4 | 59 | 2 | IPR004240 | |
| Domain | UAA | 5.86e-05 | 4 | 59 | 2 | PF08449 | |
| Domain | PC1 | 5.86e-05 | 4 | 59 | 2 | IPR000434 | |
| Domain | Dpy19 | 5.86e-05 | 4 | 59 | 2 | PF10034 | |
| Domain | Dpy-19/Dpy-19-like | 5.86e-05 | 4 | 59 | 2 | IPR018732 | |
| Domain | EMP70 | 5.86e-05 | 4 | 59 | 2 | PF02990 | |
| Domain | Aden_trnslctor | 9.27e-05 | 28 | 59 | 3 | IPR002113 | |
| Domain | Mit_carrier | 1.39e-04 | 32 | 59 | 3 | IPR002067 | |
| Domain | PKD1_2_channel | 5.30e-04 | 11 | 59 | 2 | IPR013122 | |
| Domain | PKD_channel | 5.30e-04 | 11 | 59 | 2 | PF08016 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 1.45e-03 | 18 | 59 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.62e-03 | 19 | 59 | 2 | PS50267 | |
| Domain | SNF | 1.62e-03 | 19 | 59 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 1.62e-03 | 19 | 59 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.62e-03 | 19 | 59 | 2 | PS00610 | |
| Domain | PTPc | 5.77e-03 | 36 | 59 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 6.74e-03 | 39 | 59 | 2 | PS50055 | |
| Domain | PTPase_domain | 7.43e-03 | 41 | 59 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 7.43e-03 | 41 | 59 | 2 | PF00102 | |
| Domain | Sushi | 1.18e-02 | 52 | 59 | 2 | PF00084 | |
| Domain | CCP | 1.26e-02 | 54 | 59 | 2 | SM00032 | |
| Domain | SUSHI | 1.35e-02 | 56 | 59 | 2 | PS50923 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A2 SLC7A8 SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 | 2.46e-08 | 249 | 40 | 9 | M5988 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.83e-07 | 238 | 40 | 8 | MM15076 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 2.51e-06 | 10 | 40 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A2 SLC7A8 SLC6A9 ABCG1 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 ANO5 | 4.19e-06 | 736 | 40 | 11 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.57e-06 | 12 | 40 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.94e-06 | 13 | 40 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 5.94e-06 | 13 | 40 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 5.94e-06 | 13 | 40 | 3 | M47703 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 6.33e-06 | 43 | 40 | 4 | M881 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 7.54e-06 | 14 | 40 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 9.41e-06 | 15 | 40 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.16e-05 | 16 | 40 | 3 | M47695 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A2 SLC7A8 SLC6A9 ABCG1 SLC8B1 SLC25A4 SLC25A5 SLC15A4 SLC35B3 ANO5 | 1.47e-05 | 681 | 40 | 10 | MM14985 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 1.68e-05 | 18 | 40 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.68e-05 | 18 | 40 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 1.99e-05 | 19 | 40 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.99e-05 | 19 | 40 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.33e-05 | 20 | 40 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.72e-05 | 21 | 40 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.14e-05 | 22 | 40 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.14e-05 | 22 | 40 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.60e-05 | 23 | 40 | 3 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.60e-05 | 23 | 40 | 3 | M47666 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.54e-04 | 37 | 40 | 3 | M1029 | |
| Pathway | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | 2.09e-04 | 41 | 40 | 3 | MM15075 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 3.48e-04 | 10 | 40 | 2 | M15371 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.25e-04 | 11 | 40 | 2 | MM15471 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 9.60e-04 | 271 | 40 | 5 | MM15406 | |
| Pathway | WP_PROTEOGLYCAN_BIOSYNTHESIS | 1.17e-03 | 18 | 40 | 2 | M39865 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.26e-03 | 288 | 40 | 5 | M16864 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.30e-03 | 19 | 40 | 2 | M27362 | |
| Pathway | REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS | 1.30e-03 | 19 | 40 | 2 | MM15107 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 1.75e-03 | 22 | 40 | 2 | M19166 | |
| Pathway | BIOCARTA_PTDINS_PATHWAY | 1.91e-03 | 23 | 40 | 2 | M8809 | |
| Pathway | WP_METABOLIC_EPILEPTIC_DISORDERS | 2.16e-03 | 91 | 40 | 3 | M48079 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 2.26e-03 | 25 | 40 | 2 | M47623 | |
| Pathway | KEGG_GALACTOSE_METABOLISM | 2.44e-03 | 26 | 40 | 2 | M4377 | |
| Pathway | KEGG_PENTOSE_PHOSPHATE_PATHWAY | 2.63e-03 | 27 | 40 | 2 | M1386 | |
| Pathway | WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA | 3.25e-03 | 105 | 40 | 3 | M39417 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.52e-03 | 108 | 40 | 3 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.61e-03 | 109 | 40 | 3 | MM15074 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 4.16e-03 | 34 | 40 | 2 | M15898 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 5.06e-03 | 123 | 40 | 3 | MM14623 | |
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 5.13e-09 | 3 | 61 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 5.13e-09 | 3 | 61 | 3 | 2829183 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12450408 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 33396658 | ||
| Pubmed | 9.89e-08 | 64 | 61 | 5 | 22865885 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 10620603 | ||
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 21370995 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 27641616 | ||
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 16120388 | ||
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 2.35e-06 | 53 | 61 | 4 | 23266187 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27048932 | ||
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 3.03e-06 | 2 | 61 | 2 | 10926541 | |
| Pubmed | The single pore residue Asp523 in PKD2L1 determines Ca2+ permeation of the PKD1L3/PKD2L1 complex. | 3.03e-06 | 2 | 61 | 2 | 21185261 | |
| Pubmed | Off-response property of an acid-activated cation channel complex PKD1L3-PKD2L1. | 3.03e-06 | 2 | 61 | 2 | 18535624 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16556444 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20538909 | ||
| Pubmed | Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. | 3.03e-06 | 2 | 61 | 2 | 16891422 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 2823266 | ||
| Pubmed | Acetic acid activates PKD1L3-PKD2L1 channel--a candidate sour taste receptor. | 3.03e-06 | 2 | 61 | 2 | 19464260 | |
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 3.03e-06 | 2 | 61 | 2 | 10974536 | |
| Pubmed | A novel PKD2L1 C-terminal domain critical for trimerization and channel function. | 3.03e-06 | 2 | 61 | 2 | 25820328 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26842067 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12112115 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 3.03e-06 | 2 | 61 | 2 | 14749836 | |
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 3.03e-06 | 2 | 61 | 2 | 11756613 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 11137296 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 33141153 | ||
| Pubmed | Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues. | 9.07e-06 | 3 | 61 | 2 | 156693 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 7825568 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 6451249 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21625513 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16831128 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 2960695 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 20406802 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 6444721 | ||
| Pubmed | Phosphofructokinase isozyme expression during myoblast differentiation. | 9.07e-06 | 3 | 61 | 2 | 2521854 | |
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 1.01e-05 | 24 | 61 | 3 | 24725412 | |
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 1.30e-05 | 26 | 61 | 3 | 33905568 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DPY19L3 ZMPSTE24 TMEM168 SLC15A4 TM9SF4 TM9SF1 DPY19L4 ITM2C PFKP LMBRD2 | 1.47e-05 | 1061 | 61 | 10 | 33845483 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.49e-05 | 84 | 61 | 4 | 25670202 | |
| Pubmed | Rapid evolution of human pseudoautosomal genes and their mouse homologs. | 1.81e-05 | 4 | 61 | 2 | 8903724 | |
| Pubmed | Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis. | 1.81e-05 | 4 | 61 | 2 | 19114711 | |
| Pubmed | Human-Specific ARHGAP11B Acts in Mitochondria to Expand Neocortical Progenitors by Glutaminolysis. | 1.81e-05 | 4 | 61 | 2 | 31883789 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 22423112 | ||
| Pubmed | Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD. | 1.81e-05 | 4 | 61 | 2 | 31489369 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 28202721 | ||
| Pubmed | The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. | 1.81e-05 | 4 | 61 | 2 | 31618756 | |
| Pubmed | The K+ channel KIR2.1 functions in tandem with proton influx to mediate sour taste transduction. | 1.81e-05 | 4 | 61 | 2 | 26627720 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 11287411 | ||
| Pubmed | H+ transport is an integral function of the mitochondrial ADP/ATP carrier. | 3.02e-05 | 5 | 61 | 2 | 31341297 | |
| Pubmed | ANT-dependent MPTP underlies necrotic myofiber death in muscular dystrophy. | 4.52e-05 | 6 | 61 | 2 | 37624892 | |
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 19812697 | ||
| Pubmed | Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. | 4.52e-05 | 6 | 61 | 2 | 17715127 | |
| Pubmed | Comparative analysis of the expression patterns of TM9SF family members in mice. | 6.32e-05 | 7 | 61 | 2 | 38719197 | |
| Pubmed | 7.77e-05 | 405 | 61 | 6 | 38187761 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | 1.06e-04 | 621 | 61 | 7 | 22794259 | |
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 16805797 | ||
| Pubmed | Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. | 1.35e-04 | 10 | 61 | 2 | 30590033 | |
| Pubmed | RNA binding proteins co-localize with small tau inclusions in tauopathy. | 1.41e-04 | 283 | 61 | 5 | 30068389 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | 1.91e-04 | 915 | 61 | 8 | 32393512 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DPY19L3 ZMPSTE24 TM9SF4 TM9SF1 DPY19L4 CPSF1 CHST12 ITM2C LMBRD2 | 2.34e-04 | 1201 | 61 | 9 | 35696571 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDS1 ABCG1 SLC8B1 SRD5A3 PTPRE KCNJ3 TM9SF4 PFKL SPPL2B KDM6A | 2.47e-04 | 1489 | 61 | 10 | 28611215 |
| Pubmed | The tumor suppressor Cdc73 functionally associates with CPSF and CstF 3' mRNA processing factors. | 2.72e-04 | 14 | 61 | 2 | 19136632 | |
| Pubmed | 2.93e-04 | 73 | 61 | 3 | 23464991 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 3.00e-04 | 182 | 61 | 4 | 32239614 | |
| Pubmed | 3.06e-04 | 183 | 61 | 4 | 36129980 | ||
| Pubmed | 3.83e-04 | 80 | 61 | 3 | 35803934 | ||
| Pubmed | 4.12e-04 | 82 | 61 | 3 | 20833797 | ||
| Pubmed | 4.55e-04 | 18 | 61 | 2 | 28049690 | ||
| Pubmed | 5.34e-04 | 212 | 61 | 4 | 19521566 | ||
| Pubmed | 5.63e-04 | 20 | 61 | 2 | 22028030 | ||
| Pubmed | GATA6 is a regulator of sinus node development and heart rhythm. | 5.63e-04 | 20 | 61 | 2 | 33443158 | |
| Pubmed | 6.14e-04 | 94 | 61 | 3 | 36584595 | ||
| Pubmed | 6.14e-04 | 94 | 61 | 3 | 25201988 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 6.22e-04 | 21 | 61 | 2 | 16125675 | |
| Pubmed | Identification of the Mitochondrial Heme Metabolism Complex. | 6.22e-04 | 21 | 61 | 2 | 26287972 | |
| Pubmed | 7.12e-04 | 403 | 61 | 5 | 30562941 | ||
| Pubmed | 7.14e-04 | 99 | 61 | 3 | 27746211 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 8.75e-04 | 422 | 61 | 5 | 27342126 | |
| Pubmed | 8.84e-04 | 25 | 61 | 2 | 20802378 | ||
| Pubmed | 1.03e-03 | 27 | 61 | 2 | 34709416 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.08e-03 | 256 | 61 | 4 | 24189400 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.09e-03 | 665 | 61 | 6 | 30457570 | |
| Pubmed | 1.28e-03 | 30 | 61 | 2 | 32867711 | ||
| Pubmed | TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis. | 1.28e-03 | 30 | 61 | 2 | 23973329 | |
| Pubmed | 1.36e-03 | 952 | 61 | 7 | 38569033 | ||
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 1.36e-03 | 31 | 61 | 2 | 19136429 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.40e-03 | 125 | 61 | 3 | 36030824 | |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 1.54e-03 | 282 | 61 | 4 | 35007762 | |
| Pubmed | 1.54e-03 | 33 | 61 | 2 | 19834762 | ||
| Interaction | SINHCAF interactions | 3.01e-06 | 135 | 60 | 6 | int:SINHCAF | |
| Interaction | HTR3A interactions | 1.74e-05 | 108 | 60 | 5 | int:HTR3A | |
| Interaction | CLEC2D interactions | 2.61e-05 | 197 | 60 | 6 | int:CLEC2D | |
| Interaction | TTYH1 interactions | 2.97e-05 | 300 | 60 | 7 | int:TTYH1 | |
| GeneFamily | Solute carriers | SLC6A2 SLC7A8 SLC6A9 SLC8B1 SLC25A4 SLC25A5 SLC25A6 SLC15A4 SLC35B3 SLC25A38 SLC35B1 | 1.10e-09 | 395 | 42 | 11 | 752 |
| GeneFamily | Transmembrane 9 superfamily members | 3.15e-05 | 4 | 42 | 2 | 1239 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 3.02e-06 | 175 | 60 | 6 | M6690 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_UP | 6.51e-06 | 200 | 60 | 6 | M4349 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLC7A8 CDS1 ABCG1 SRD5A3 SEMA6D PTPRE TNFSF13B CHST12 ITM2C GSAP PFKP SVEP1 | 2.06e-05 | 1242 | 60 | 12 | M1920 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.32e-05 | 681 | 60 | 9 | M5314 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.97e-05 | 703 | 60 | 9 | MM1055 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | SLC7A8 CDS1 ABCG1 SRD5A3 SEMA6D PTPRE TNFSF13B CHST12 ITM2C GSAP PFKP SVEP1 | 3.64e-05 | 1316 | 60 | 12 | MM1052 |
| Coexpression | GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP | 8.90e-05 | 197 | 60 | 5 | M4682 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 9.12e-05 | 198 | 60 | 5 | M9407 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP | 9.12e-05 | 198 | 60 | 5 | M5015 | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 5.79e-06 | 187 | 61 | 5 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 5.79e-06 | 187 | 61 | 5 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.26e-06 | 190 | 61 | 5 | e59e3ad044af7b4409d5ecbd326fe83862e5fc9a | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-06 | 194 | 61 | 5 | 3043f6230fa723037c8cf7123f611ae847b39fd4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-06 | 194 | 61 | 5 | 607b5d194ba56efa9b106f10f89368fc103712a0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-06 | 194 | 61 | 5 | f5367072b259ae170cf0df3d4d871ab41be29d29 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 7.10e-06 | 195 | 61 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-06 | 198 | 61 | 5 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.83e-06 | 199 | 61 | 5 | 2f6074a2fd3323f258be03042f77929640ad0a75 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cadm1_(Cerebellum_basket_cells_3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.71e-05 | 51 | 61 | 3 | 0611419cc63dbe772d10c1f6f96826786351f048 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Cadm1_(Cerebellum_basket_cells_3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.71e-05 | 51 | 61 | 3 | a673b6d6ddecb7c239cb49ff490188460edc87e0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.21e-05 | 149 | 61 | 4 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 160 | 61 | 4 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 7.03e-05 | 161 | 61 | 4 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | Monocytes-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.73e-05 | 165 | 61 | 4 | 83d06210a50073fbb7082eabd8298dd355c40416 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.92e-05 | 166 | 61 | 4 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 8.29e-05 | 168 | 61 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 169 | 61 | 4 | 42c31fe94e34f54dbbb5d8b33cedb55badd6232c | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 8.48e-05 | 169 | 61 | 4 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.68e-05 | 170 | 61 | 4 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.88e-05 | 171 | 61 | 4 | 4fd2c7977c512c51507f055fc74b111c0228ed8b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.88e-05 | 171 | 61 | 4 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.50e-05 | 174 | 61 | 4 | 31f7127faabcb1092bb9827db625f57cf7d8240e | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.50e-05 | 174 | 61 | 4 | 8a8e98e62c2859c004b44dbce6974c9639ebeac6 | |
| ToppCell | IIF-Myeloid-pDC|IIF / Disease, Lineage and Cell Type | 9.71e-05 | 175 | 61 | 4 | 35cfb7d0b88678ff5b83ad6e19dbc15a908a3fcc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.71e-05 | 175 | 61 | 4 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 176 | 61 | 4 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 177 | 61 | 4 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 177 | 61 | 4 | 8887ff6341eb070bdaa890cc2cd7745f0cf1b0af | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 177 | 61 | 4 | 507f06d31ab773099c9431b6f433899dc97b5566 | |
| ToppCell | RSV-Healthy-4|RSV / Virus stimulation, Condition and Cluster | 1.04e-04 | 178 | 61 | 4 | a5835951492c051443f3c30d45f9a7b1b2557477 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 178 | 61 | 4 | 50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69 | |
| ToppCell | RSV-Healthy-4|Healthy / Virus stimulation, Condition and Cluster | 1.04e-04 | 178 | 61 | 4 | a6d71aebb5c462311f8ade24f659642b6b329633 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 179 | 61 | 4 | c9f45cfea0ceb0cdc31bcfd123aeab69aeb35c35 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 179 | 61 | 4 | bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 179 | 61 | 4 | 4808469096cd6bec2bdfcf4fc55aa324757600c3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 179 | 61 | 4 | 4d55718c6afd8a038d93cc77b9b08171dab9976f | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 180 | 61 | 4 | 6a2366d76276452141db1bd93013a9503525f574 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 180 | 61 | 4 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 180 | 61 | 4 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 180 | 61 | 4 | 40f79b4455dbd1c2720dc32d9d77c70f835cecb3 | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|tumor_Lung / Location, Cell class and cell subclass | 1.11e-04 | 181 | 61 | 4 | c864ffeb9234b8c29754afc91c85a972889617f4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 182 | 61 | 4 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.13e-04 | 182 | 61 | 4 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 182 | 61 | 4 | 02c0824373a0ecebc922d4ca848ace9d570722c4 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.15e-04 | 183 | 61 | 4 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.15e-04 | 183 | 61 | 4 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 184 | 61 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Leuk-UTI-Other-RBC|Leuk-UTI / Disease, Lineage and Cell Type | 1.20e-04 | 185 | 61 | 4 | 5b5dd856d6efc0539d92533cff134bbc3f98be45 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 185 | 61 | 4 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.20e-04 | 185 | 61 | 4 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | Leuk-UTI-Other|Leuk-UTI / Disease, Lineage and Cell Type | 1.20e-04 | 185 | 61 | 4 | 895e8087e97ac0eab3446385e6e0dd24bea7f42c | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 185 | 61 | 4 | 94d0f283d63d932f310cc5a17ea893d71ba60f5e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 186 | 61 | 4 | 0096a61b1841784c913752b4f3639200446cc02c | |
| ToppCell | Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.23e-04 | 186 | 61 | 4 | 330a4f669adea91ff9f2dff2de2210f5e3401e19 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 186 | 61 | 4 | 6345777847960c71a2ba3ce5a49c72c34ebd0e73 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 186 | 61 | 4 | 9e159ad7289dcae2ec7ce655df746f46801b81d3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 61 | 4 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 61 | 4 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | B_cell_maturation-immature_B_cell|B_cell_maturation / Lineage and Cell class | 1.25e-04 | 187 | 61 | 4 | 9afbb21654c8eb6f9c6a7cbd0664d890282ddceb | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.25e-04 | 187 | 61 | 4 | a3592f056e1c2f82ba325fea2ecc4dd6c6347c81 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-04 | 187 | 61 | 4 | e5713a7bda53d1d5178ab4e0dbadc2292b6005bc | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 1.25e-04 | 187 | 61 | 4 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 61 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 188 | 61 | 4 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-04 | 188 | 61 | 4 | 2b630b0609d4ac61338d6533cb7893cfe1241e44 | |
| ToppCell | COVID-19_Mild-pDC|COVID-19_Mild / Disease condition and Cell class | 1.28e-04 | 188 | 61 | 4 | 62d33d2990d4a2d32bd0863147e47f656df1966e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 61 | 4 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | COVID-19_Mild-pDC-|COVID-19_Mild / Disease condition and Cell class | 1.28e-04 | 188 | 61 | 4 | a75c2cf2f8dae343c13aaa66b637658b935ed10a | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.33e-04 | 190 | 61 | 4 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | MS-pDC-|MS / Condition, Cell_class and T cell subcluster | 1.33e-04 | 190 | 61 | 4 | f56ec302d556ace4f7609017a35c311cf43aa8a5 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 1.33e-04 | 190 | 61 | 4 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.33e-04 | 190 | 61 | 4 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | MS-pDC|MS / Condition, Cell_class and T cell subcluster | 1.33e-04 | 190 | 61 | 4 | f41d7ab7d7fbcd73fddb6c3533c6a3e642e3d07f | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 190 | 61 | 4 | d06800ec9f6065c1cc536ed99e8569732272a94f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 190 | 61 | 4 | 7179f980f895d3e5b839b5ae26b5c991787bfe3a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 190 | 61 | 4 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-04 | 190 | 61 | 4 | 485073e831afebdb393c7f4b622504d43d1b778b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 191 | 61 | 4 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | f4a425a0e7382d01b5a8201c2c186966bb47011b | |
| ToppCell | HSPCs-Gran/Mono_prog.|HSPCs / Lineage and Cell class | 1.36e-04 | 191 | 61 | 4 | 54620502e6aea0a615b664e861e0044dd9e0ad91 | |
| ToppCell | facs-Brain_Myeloid-Striatum_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | de3b696de29a4b10c0870dec1792c7be9651d31e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.36e-04 | 191 | 61 | 4 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | e0c9f49d2e26ccbc88b4ceae9918922f4b7cfd4d | |
| ToppCell | Control-Myeloid-pDC|Control / Disease, Lineage and Cell Type | 1.36e-04 | 191 | 61 | 4 | 473f904fe244d919ce561139591a2be12cc9fa6b | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | fe17533b970540ad3339722e13dbf4029b20a756 | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 191 | 61 | 4 | d031430687b876930e9f718da20679938fd05edc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 192 | 61 | 4 | 32927ef3b93e0497e9bbe63c2754da03cf178202 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 192 | 61 | 4 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 192 | 61 | 4 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | BLOOD--(3)_DC_(cDC+pDC)| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.39e-04 | 192 | 61 | 4 | e290c55a1321e9e577f49e8ba20501b2c8150044 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 192 | 61 | 4 | 3b0a52e4e77ae4539a034dcb419773b8e2aa5d51 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 193 | 61 | 4 | c6633aca0eb4d699c4d3da3199b84bebd87e2d31 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-04 | 193 | 61 | 4 | 30abf991ac17c18679ab7d633e7549c0ce841920 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 193 | 61 | 4 | a32791b4bdb7c5f2b4cc75b660321ab75c4fac9b | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-04 | 193 | 61 | 4 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 194 | 61 | 4 | 66dd0469db797c61b094f47426b5212fe52156e9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-04 | 194 | 61 | 4 | 3f9e4a8e5699bc379e8a0d337e0daef09632e71c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 194 | 61 | 4 | 840220fe357e6e79fb60a530798be2dc12ce8f32 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.44e-04 | 194 | 61 | 4 | 5250736b608001fb73aa74dee8cb8465a1d2f372 | |
| Drug | Clodronate | 1.74e-08 | 3 | 60 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 6.95e-08 | 4 | 60 | 3 | ctd:C000600819 | |
| Drug | closantel | 6.04e-07 | 7 | 60 | 3 | ctd:C023342 | |
| Drug | AC1L4X2K | 2.06e-06 | 10 | 60 | 3 | CID000193824 | |
| Drug | oleoylcarnitine | 9.51e-06 | 16 | 60 | 3 | CID006441392 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.14e-05 | 192 | 60 | 6 | 6958_UP | |
| Drug | beta-hydroxypalmitoyl-CoA | 1.15e-05 | 17 | 60 | 3 | CID000440600 | |
| Drug | creatine | 1.17e-05 | 193 | 60 | 6 | CID000000586 | |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; PC3; HT_HG-U133A | 1.32e-05 | 197 | 60 | 6 | 4315_UP | |
| Drug | phosphoenolpyruvate | 1.90e-05 | 210 | 60 | 6 | CID000001005 | |
| Drug | agaric acid | 1.92e-05 | 20 | 60 | 3 | CID000012629 | |
| Drug | carboxyatractyloside | 2.05e-05 | 3 | 60 | 2 | ctd:C003853 | |
| Drug | phenylsuccinate | 2.24e-05 | 21 | 60 | 3 | CID000095459 | |
| Drug | Uridine diphosphate 2-deoxyglucose | 4.08e-05 | 4 | 60 | 2 | CID000165519 | |
| Drug | L 012 | 6.05e-05 | 29 | 60 | 3 | CID000126741 | |
| Drug | HCOH (hydroxymethylene) | 7.42e-05 | 31 | 60 | 3 | CID006432217 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 2.88e-08 | 4 | 58 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | glycogen storage disease (implicated_via_orthology) | 2.27e-05 | 4 | 58 | 2 | DOID:2747 (implicated_via_orthology) | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.54e-05 | 29 | 58 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 4.51e-05 | 35 | 58 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Methionine sulfoxide measurement | 2.47e-04 | 12 | 58 | 2 | EFO_0021650 | |
| Disease | attention deficit hyperactivity disorder, Cannabis use | 5.69e-04 | 18 | 58 | 2 | EFO_0003888, EFO_0007585 | |
| Disease | disease of metabolism (implicated_via_orthology) | 7.78e-04 | 21 | 58 | 2 | DOID:0014667 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQGIIIYRAAYFGVY | 181 | P12236 | |
| GFIAAYVLSKYQYFV | 291 | Q92903 | |
| YGEKIGIYFVFLGFY | 296 | Q75V66 | |
| YVRYGFEGVILSIYG | 601 | P45844 | |
| GSIVFKEVGYYNVYA | 501 | P41180 | |
| VQGIIIYRAAYFGIY | 181 | P05141 | |
| VYFYIYTLFGLQAIY | 156 | Q6ZPD9 | |
| LFFIFYYLEGTKAQY | 671 | O75175 | |
| TLINYVGFINYLFYG | 386 | Q9UHI5 | |
| FYAIAGGLFLERAYY | 1051 | Q9NRD9 | |
| FIYQALLEYYLYGDT | 386 | P23469 | |
| YSFFFLDYVGVAVYQ | 136 | Q86WK9 | |
| FKYVIYGIAAAFFVY | 81 | P51674 | |
| FLFYLLIQTVGFFGY | 466 | Q9HAT1 | |
| AFLYGLGLVYFHYNA | 131 | O15550 | |
| FRYFEDIYGYSGVFI | 931 | Q10570 | |
| GIYVGAKVFLIYEGY | 41 | P17858 | |
| IYVGAKVYFIYEGYQ | 51 | Q01813 | |
| LVVFLFYGSASYGYL | 246 | O95371 | |
| YFEYILYDVGVYGCQ | 381 | Q9NY59 | |
| GLVFASVYIYRYFFL | 71 | Q9NQX7 | |
| YALEPTVYFGVVFYV | 91 | Q16825 | |
| IYFITFGLYYGIFGT | 346 | A8MWK0 | |
| VQYCFGLVYYVLVGL | 161 | Q9H8P0 | |
| YFFIFREGDGVYYNE | 311 | Q8N7H5 | |
| GITFLNLDYYVAVYL | 336 | A4D1B5 | |
| SIFYKGVYYQIGDVV | 141 | Q8WUU5 | |
| GFYYTGLYSEIFFII | 111 | P32246 | |
| VFEVGFLIGQYFLYG | 186 | P36383 | |
| VYFYIGIVFGLQGIY | 161 | Q7Z388 | |
| LYIIKIGGDYFFIYA | 186 | O75844 | |
| YLNYYFFLLAAIQGA | 531 | Q8N697 | |
| YAGGFAIVYYLIQKF | 26 | Q9GZY4 | |
| FLVGNLGLVYLIYYE | 46 | Q8NH56 | |
| LGYLGLYVFYVVTVI | 231 | Q6J4K2 | |
| VILIALYVGFYYNVI | 141 | P23975 | |
| YYVLGFGIFLFIVAG | 151 | P0DP42 | |
| NAIYYGTYLLIFGAF | 151 | Q68DH5 | |
| VIYYLLVCYYAFIQG | 1471 | Q7Z443 | |
| AGVFVFYLIYGYLQE | 86 | Q9H1N7 | |
| FYLIYGYLQELIFSV | 91 | Q9H1N7 | |
| VLYSYSIGFVYILLG | 261 | Q9H1N7 | |
| QGYDGYFVLSVEQYL | 2691 | Q9UKZ4 | |
| FVEGADYSYGAIIIY | 2566 | Q4LDE5 | |
| VFVCYFYYGILQEKI | 21 | P78383 | |
| VGIYFGTLYSLKQYF | 101 | Q96DW6 | |
| VQGIIIYRAAYFGVY | 181 | P12235 | |
| QLYKLYEADFVLFGY | 391 | Q9NRB3 | |
| QLYYKSYFLFIFGIE | 226 | Q8TCW9 | |
| QEIIGQLDYYLYGNY | 606 | Q86Y38 | |
| GGSAFYVLVYAIFYF | 576 | Q92544 | |
| LLIYKLSYAFGVVGY | 141 | Q8N4F7 | |
| YYFYDLLVYVVIGIF | 241 | Q8TCT7 | |
| NLFYFCIIVYLYGDL | 146 | Q8NE00 | |
| YIGIYYNVVICIAFY | 191 | P48067 | |
| CFFYISVYPGYGVEI | 271 | Q53EL9 | |
| GLFVLGIASILYYYF | 71 | Q9H0V1 | |
| IVFFAYAQLGYLLFG | 486 | Q9P0L9 | |
| GIIRLFYFYKEGLYL | 166 | Q6P2C0 | |
| GYFFIYGQVLYTDKT | 191 | Q9Y275 | |
| AIEYGNYVYFFFREI | 226 | Q8NFY4 | |
| GREQYTLYGILFFVF | 491 | O15321 | |
| FFIETEATIGYGYRY | 136 | P48549 |